Project

TB CARE I in Nigeria

FHI 360 is implementing the TB CARE I project, which supports Nigeria’s efforts to reduce the burden of tuberculosis (TB) and HIV. The project contributes to global and national TB control targets and addresses multidrug-resistant TB (MDR-TB). In partnership with the National and State TB and Leprosy Control Program and with community-based organizations, FHI 360 is strengthening community TB care interventions through trained community volunteers in 19 local government areas across nine states and the Federal Capital Area. FHI 360 is also supporting MDR-TB infection control, diagnosis and treatment through the reference laboratory at Lawrence Henshaw Memorial Hospital, Calabar; and the renovation and upgrade of two wards (Lagos Mainland Hospital and Infectious Diseases Hospital in Kano) into MDR-TB treatment centers. FHI 360 has also upgraded the Nigerian Institute of Medical Research laboratory to a biosafety level-3 standard.

For information regarding TB CARE I's work in other countries, please click here.

Countries:
  • Nigeria
Funder: USAID, Royal Dutch Chemical Association (KNCV)
Duration: 2010 - 2015